CD19 and B-cell chronic lymphocytic leukemia: Consistent with our previous study that was based on goat anti-human ROR1 pAbs [20], IgG1 R11, R12, and Y31 selectively bound to CLL cells (CD19+ CD5+), but not to normal T cells (CD19− CD5+) or other normal leukocytes.